A systematic review update of the clinical effectiveness and cost-effectiveness of glycoprotein IIb/IIIa antagonists.
Robinson
M
M
Nuffield Institute for Health, University of Leeds, UK.
Ginnelly
L
L
Sculpher
M
M
Jones
L
L
Riemsma
Palmer
S
S
Philips
Z
Z
Glanville
J
J
D003327:Coronary Disease / Q000188:drug therapy* / Q000191:economics*; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000191:economics* / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D015912:Thrombolytic Therapy; D016896:Treatment Outcome; D006113:United Kingdom
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex